Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Robinson

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Acta Neuropathologica|October 18, 2023
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterationsHolly J Roberts, Sunjong Ji, Alberto Picca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2015
ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer PatientsDavid Chu, Costanza Paoletti, Christina Gersch, et al.
Oncotarget|November 23, 2017
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategyDaniel H Hovelson, Chia-Jen Liu, Yugang Wang, et al.
The New England Journal of Medicine|July 20, 2016
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate CancerColin C Pritchard, Joaquin Mateo, Michael F Walsh, et al.
Nature Genetics|June 2, 2019
Publisher Correction: The long tail of oncogenic drivers in prostate cancerJoshua Armenia, Stephanie A M Wankowicz, David Liu, et al.
Nature Genetics|April 4, 2018
The long tail of oncogenic drivers in prostate cancerJoshua Armenia, Stephanie A M Wankowicz, David Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2019
Genomic correlates of clinical outcome in advanced prostate cancerWassim Abida, Joanna Cyrta, Glenn Heller, et al.
The New England Journal of Medicine|October 29, 2015
DNA-Repair Defects and Olaparib in Metastatic Prostate CancerJoaquin Mateo, Suzanne Carreira, Shahneen Sandhu, et al.
The Journal of Clinical Investigation|September 5, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancerDaniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
The Journal of Clinical Investigation|November 2, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancerDaniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Acta Neuropathologica|October 18, 2023
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterationsHolly J Roberts, Sunjong Ji, Alberto Picca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2015
ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer PatientsDavid Chu, Costanza Paoletti, Christina Gersch, et al.
Oncotarget|November 23, 2017
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategyDaniel H Hovelson, Chia-Jen Liu, Yugang Wang, et al.
The New England Journal of Medicine|July 20, 2016
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate CancerColin C Pritchard, Joaquin Mateo, Michael F Walsh, et al.
Nature Genetics|June 2, 2019
Publisher Correction: The long tail of oncogenic drivers in prostate cancerJoshua Armenia, Stephanie A M Wankowicz, David Liu, et al.
Nature Genetics|April 4, 2018
The long tail of oncogenic drivers in prostate cancerJoshua Armenia, Stephanie A M Wankowicz, David Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2019
Genomic correlates of clinical outcome in advanced prostate cancerWassim Abida, Joanna Cyrta, Glenn Heller, et al.
The New England Journal of Medicine|October 29, 2015
DNA-Repair Defects and Olaparib in Metastatic Prostate CancerJoaquin Mateo, Suzanne Carreira, Shahneen Sandhu, et al.
The Journal of Clinical Investigation|September 5, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancerDaniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
The Journal of Clinical Investigation|November 2, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancerDaniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
Pageof 5